Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZODIAK trial of zoledronic acid in knee osteoarthritis
NL-OMON50547Phase 2Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in knee osteoarthritis (OA) and osteoarthritis (OA) comparing Zoledronic acid with Placebo (2 arms). Primary endpoint: Change in cartilage thickness in the most affected compartment. Started Aug 2018; status: active, not recruiting.
02
Drugs
zoledronic acid
03
Conditions
knee osteoarthritis (OA)osteoarthritis (OA)
Beyond the preview
Go deeper on NL-OMON50547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50547.